Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Henlius Collaborates with HanchorBio to Develop Novel Immuno-Biologics

publication date: Aug 28, 2023

Shanghai Henlius Biotech will collaborate with Taipei’s HanchorBio to discover novel immuno-biomedicines using Hanchor’s Fc-based designer biologics (FBDB™) platform. The collaboration will focus on developing novel drugs for patients with tumors resistant to anti-PD-1/L1 immunotherapies. Henlius will have rights for early licensing and/or co-development of promising Hanchor products. Once the collaboration reports efficacy/safety data, the companies will announce details of partnerships. HanchorBio was founded by Dr. Scott Liu who also co-founded Henlius, a company that formed a Shanghai JV and was taken over by Fosun Pharma. More details....

Stock Symbol: (HK: 2696)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here